Trial
NCT04363866
Assessing Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19)
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Oregon Health and Science University
Collaborators
OHSU Knight Cancer Institute
Condition
COVID-19
Intervention
Hydroxychloroquine
Why stopped
discontinued in favor of more promising directions that may benefit patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-10-29